1Department of Orthopedics, Faculty of Medicine Prince of Songkla University, Songkhla, Thailand, 2Department of Orthopedics Surgery, Faculty of
Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
ABSTRACT
INTRODUCTION
Distraction osteogenesis (DO) is a well-known method in orthopedic surgery.1,2 This technique creates new bone formation using the principle of Tension-Stress. Under a slow and gradual traction force, the cells in the
distraction gap become metabolically active, leading to osteogenesis.3,4 DO is used in adult and pediatric patients. In adults, it is used mainly for bone defects caused by trauma, infection, or tumor. In pediatric patients, conditions such as congenital limb deficiency,
Corresponding author: Perajit Eamsobhana E-mail: perajite@gmail.com
Received 2 January 2024 Revised 27 March 2024 Accepted 29 March 2024 ORCID ID:http://orcid.org/0000-0002-2634-1175 https://doi.org/10.33192/smj.v76i6.266954
All material is licensed under terms of the Creative Commons Attribution 4.0 International (CC-BY-NC-ND 4.0) license unless otherwise stated.
physeal arrest, or osteomyelitis that result in limb length discrepancy (LLD) are major indications.5,6
DO includes the initial, distraction, and consolidation phases. The rate and frequency during distraction have been shown to affect the quality of osteogenesis.3,4,7 In a detailed animal model study, It was demonstrated that the optimal speed for lengthening is around 1 mm per day. In addition, increasing the frequency of distraction may improve osteogenesis, but this has not been proved in a clinical study. Many factors can also affect the healing index (HI), for examplem, the patient’s age, the extent of the lengthening, the lengthened bone segment, the device used, and etiologies.7-10 Many devices have been used for DO. The two most commonly used devices were the ring external fixator and the monolateral fixator. These can be combined with some form of internal fixation to reduce time in the external fixator, called integrated lengthening.
In our institution, a lengthening frequency of four times a day (QID) is the standard method. However, some patients do not fully follow the protocol and prefer a lower frequency of distraction. Therefore, two times a day (BID) lengthening was used in some patients. However, the effect of lengthening frequency has not been tested clinically. Therefore, here our objective is to compare the results and complications between the lengthening frequency of BID and QID.
MATERIALS AND METHODS
Study design and setting
The institutional review board has approved this retrospective cohort study. Patients who underwent DO in our institution over ten years from January 2010 to January 2020 were recruited.
Participants and data collection
The inclusion criteria for this study are patients who received DO at our institution. All types of devices used, consolidation methods and all etiologies for DO were included. Patients were excluded if a concurrent correction for deformity was also performed. Patients who did not have clinical and radiological follow-up until the DO process was complete were also excluded. At the time of operation, demographic data such as age, body weight, body height, and gender were collected. The patient’s diagnosis was collected. DO data were recorded, including bone segment, devices used, consolidation method, lengthening rate, and lengthening frequency. The decision to use a mono-lateral fixator or Illizarov apparatus and the lengthening frequency was up to the surgeon’s preferences. Radiographs were reviewed for
initial bone length, length gain, and callus quality. All complications during and after the DO process were recorded.
Outcome measurement
The healing index (HI) is the primary outcome of this study. It is computed by dividing the number of days spent on DO by the length of the developed callus in centimeters (cm).8,11 In our study, the duration of DO starts on the day of osteotomy and ends when the callus is fully consolidated, and full weight bearing is permitted for the patient. HI should be less than 45 days/ cm to achieve optimal treatment time.12 External fixator index (EI) is calculated similarly, but the period is from applying the external fixator until it was removed.
Secondary outcomes involve the quality of the callus formed and the complications that occur. The callus quality is assessed using the callus’s shape, density, and pathway according to Li et al.13 The callus shape is classified into fusiform, cylindrical, concave, lateral, and central. Fusiform and cylindrical shapes were grouped as “Good callus shapes”.
The callus pathway was categorized into four distinct types: sparse, homogeneous, heterogeneous, and lucent. Each of these categories is subsequently subdivided into three density levels: low, intermediate, and normal. Homogeneous and heterogeneous types with intermediate and normal density callus are grouped as “Good callus density”. The callus score when the external fixator was removed was also recorded.14 Complications were classified into problems, obstacles, minor and major complications according to Paley et al.5 The subsidence of the callus is defined as the change in callus > 10% or angulation > 10 degrees.14
Treatment protocol
Osteotomy technique: All patients received the same technique for osteotomy. We did an osteotomy at the metaphysodiaphyseal area of the distal femur and proximal tibia. The bone was drilled, and the osteotomy was completed with an osteotome. We checked the osteotomy completion by slight distraction under a fluoroscope.
External fixator application: Two types of exernal fixators were used in our patients. The decision to use the Illizarov frame or monolateral fixators is based on surgeon’s preferences. For the Ilizarov frame, it was assembled and applied to the bone proximally and distally. Transosseous elements that engage at least four cortices in each segment using Shanz pins and wires were inserted according to the safe zone. For the monolateral fixator,
we inserted three Shanz pins, size 5.0 mm – 6.0 mm, into the proximal shaft and the distal shaft area.
Lengthening Protocol: The initial phase is seven days for all patients. The patient and caregiver were then instructed to manually distract the device BID (0.5 mm x two steps) or QID (0.25 mm x four steps). Both groups utilize the same rate of one mm/day.
Follow-up and Consolidation methods: Serial radiographs and clinical exams were scheduled every two weeks. If the patient complains of pain or has a reduced range of motion, the rate can be modified. The actual distraction rate was calculated when the distraction is fisnished by dividing the length gained by the days used. After reaching the desired length, if plate fixation or casting were chosen as a consolidation method, the external fixator was kept until some ossification of the lengthening site was observed, then converted to plate or casting. However, the cut point for conversion to plate/ cast consolidation is up to the surgeon’s preferences. After solid consolidation was observed, the patients were allowed to bear weight.
A histogram and the Shapiro-Wilk test were used to investigate data distribution patterns. The independent T-test was used to test normally distributed continuous data with mean ± SD. The Mann-Whitney U test was used to evaluate nonnormally distributed continuous variables with median and interquartile range (IQR). Categorical data were provided as counts and percentages, and Fisher’s exact probability test was used to test them. The statistical significance level was chosen at p 0.05. STATA 16 (StataCorp, LLC, College Station, TX, USA) was used for all statistical analyses.
We use the inverse probability of treatment weighting (IPTW) to balance baseline covariates between the two treatment groups. The IPTW is a propensity score method that will weigh treatment effects with the probability of receiving treatments to account for potential selection biases in the non-randomized study. The IPTW was calculated based on baseline covariates, including options of conversion for consolidation, external fixator type (Ilizarov or Monolateral fixator), the etiology being congenital limb deficiency, the magnitude of length gain, distraction rate, patient’s age, and bone lengthed (femur or tibia). Subsequently, the average treatment effects (ATE) between the QID and BID groups for HI, the probability of having good callus density and shape, and complications were calculated under IPTW. Any covariates demonstrating a weighted absolute Standardized Difference (STD) of greater than 10% were included for a double robustness adjustment in the weighted analysis.
RESULTS
We included 72 patients in our study. The demographic data of patients who received BID and QID lengthening is compared in (Table 1). There were significantly more male patients in the QID group. More patients in the QID group were lengthened with Illizarov frame and converted to cast for consolidation. Sixteen patients ( 21.6%) had LLD from congenital causes, which comprised six Fibular hemimelia (8.1%), four Congenital femoral deficiency (5.4%), three Tibial hemimelia (4.1%) and three Hemihypertrophy (4.1%). Fifteen patients (20.3%) had limb undergone DO due to physeal injury from either traumatic or infectious causes. Eight patients (10.8%) had chronic osteomyelitis (COM), requiring DO to reconstruct the bone defect. We used DO for Congenital tibial dysplasia in four cases (5.4%). The remaining 31 patients have various causes leading to LLD, which are six Perthes diseases (8.1%), six Developmental hip dysplasia (8.1%), four Syndrome associated (5.6%), three Blount’s disease (4.1%), three Posteromedial tibial bowing (4.1%), three Bone tumor (4.1%), two skeletal dysplasia (2.7%), two Malunion (2.7%), one Arthrogryposis (1.4%), and one Cerebral palsy (1.4%). The lengthening outcomes and complications of the two groups are compared in (Table 2), showing no significant differences between the two groups.
Effects of Lengthening Frequency on Healing Index
A higher proportion of patient in QID group achieved H-index < 45 days/cm; QID group (27 out of 46 patients, 58.7%) vs. BID group (12 out of 28 patients, 42.9%). However the difference did not reach statistical significant, P = 0.2786). Subgroup analysis for factors that influence HI were evaluated by univariate and multivariate analysis (Table 3). QID lengthening has an OR of 1.89 ( 95%CI 0.73-4.90, p = 0.188) for achieving HI <45 days/ cm. The multivariable analysis results in OR of 1.12 (95%CI 0.31-3.99, p = 0.862). Influencing factors were adjusted using IPTW to determine the average effect of lengthening frequency treatment (QID vs. BID) (Fig 1). QID lengthening did not have a significant impact on HI (52.8±24.0 days/cm vs. 50.5±17.1 days/cm, Average treatment effect (ATE) = 2.3 (-5.8 to 10.4), p = 0.577). In other words, if all patients received QID lengthening instead of BID lengthening, the HI would be about 2.3 days/cm more. QID lengthening also did not significantly affect achieving good callus shape and density.
Effects of Lengthening Frequency on Complications
The complication rate of DO, which included Problems (28.57% vs. 19.57%, p = 0.404), Obstacles (39.28% vs.
28.26%, p = 0.443), Minor and Major complications
TABLE 1. Demographic data of patients receiving distraction osteogenesis by lengthening frequency
Demographic data | 2 times/day (BID) (n=28, 37.8 %) | 4 times/day (QID) (n=46, 62.2 %) | P-value | ||
Mean | ±SD | Mean | ±SD | ||
Clinical characteristics Age (years) | 15.3 | 8.6 | 13.4 | 9.8 | 0.410 |
Sex (n,%) Male | 9 | 32.1 | 27 | 58.7 | 0.033* |
Female | 19 | 67.9 | 19 | 41.3 | |
Body weight (kg) | 42.7 | 18.6 | 38.9 | 18.0 | 0.384 |
Body height (cm) | 144.2 | 20.9 | 137.2 | 22.8 | 0.187 |
Bone lengthened (n, %) | |||||
Femur | 17 | 60.7 | 24 | 52.2 | 0.630 |
Tibia | 11 | 39.3 | 22 | 47.8 | |
Lengthening device (n, %) Ilizarov frame | 16 | 57.1 | 37 | 80.4 | 0.038* |
Wagner frame | 12 | 42.9 | 9 | 19.6 | |
Consolidation method (n, %) No conversion | 2 | 7.1 | 6 | 13.0 | 0.020* |
Conversion to Casting | 12 | 42.9 | 34 | 73.9 | |
Conversion to plate fixation | 14 | 50.0 | 6 | 13.1 | |
Etiologies of LLD1 (n, %) Congenital limb deficiency | 9 | 32.1 | 7 | 15.2 | 0.138 |
Physeal injury | 6 | 21.4 | 9 | 19.6 | |
Chronic osteomyelitis | 1 | 3.6 | 7 | 15.2 | |
Congenital pseudarthrosis of tibia | 0 | 0.0 | 4 | 8.7 | |
Other acquired causes | 12 | 42.9 | 19 | 41.3 |
1LLD, Limb length discrepancy; Normally distributed continuous data were compared using an Independent T-test. Categorical data were analyzed using Fisher’s Exact Test for small sample sizes and Pearson's Chi-Square Test for larger samples.
TABLE 2. Lengthening outcomes and complications of patients receiving distraction osteogenesis by frequency of distraction
2 times/day (BID) (n=28, 37.8 %) | 4 times/day (QID) (n=46, 62.2 %) | P-value | |||
Mean | ±SD | Mean | ±SD | ||
Lengthening data | |||||
Initial Bone length (cm) | 31.62 | 8.68 | 29.44 | 8.67 | 0.299 |
Length gain (cm) | 6.14 | 2.40 | 5.55 | 2.31 | 0.294 |
Lengthening rate (mm/days) | 0.71 | 0.15 | 0.75 | 0.19 | 0.391 |
Lengthening outcomes | |||||
Healing index < 45 days/cm (n, %) | 12 | 42.9 | 27 | 58.7 | 0.279 |
Callus qualities | |||||
Achieved Good callus density (n, %) | 9 | 32.14 | 15 | 32.6 | 1.000 |
Achieved Good callus shape (n, %) | 11 | 39.28 | 26 | 56.52 | 0.231 |
Callus score | 5.89 | 1.75 | 6.57 | 1.71 | 0.108 |
Callus subsidence (n, %) | 9 | 32.14 | 18 | 39.13 | 0.623 |
Complications | |||||
Problems (n, %) | 8 | 28.57 | 9 | 19.57 | 0.404 |
Obstacles (n, %) | 11 | 39.28 | 13 | 28.26 | 0.443 |
Minor and Major complications (n, %) | 9 | 32.14 | 12 | 26.09 | 0.604 |
Normally distributed data was compared with an Independent T-test. Categorical data was compared with Fisher’s Exact Test.
TABLE 3. Univariable and multivariable logistic regression for factors predicting good healing index (<45 days/cm)
Characteristics Univariable analysis Multivariable analysis | ||||||||
uOR | 95%CI | p-value | mOR | 95%CI | p-value | |||
Conversion to plate | 0.49 | 0.17 | 1.41 | 0.187 | 0.59 | 0.16 | 2.29 | 0.736 |
Illizarov | 2.29 | 0.81 | 6.45 | 0.117 | 3.56 | 0.85 | 14.96 | 0.083 |
Congenital causes | 0.32 | 0.10 | 1.04 | 0.060 | 0.13 | 0.02 | 0.72 | 0.019 |
Length > 5 cm | 2.13 | 0.84 | 5.41 | 0.110 | 2.22 | 0.72 | 6.81 | 0.163 |
Rate < 0.7 mm/day | 2.12 | 0.83 | 5.42 | 0.118 | 3.09 | 0.97 | 9.81 | 0.056 |
Age < 10 | 1.33 | 0.518 | 3.433 | 0.551 | 3.16 | 0.69 | 14.48 | 0.137 |
Femur | 2.12 | 0.83 | 5.40 | 0.114 | 3.93 | 1.11 | 13.97 | 0.034 |
QID1 lengthening | 1.89 | 0.73 | 4.90 | 0.188 | 1.12 | 0.31 | 3.99 | 0.862 |
1QID, 4 times per day |
(32.14% vs. 26.09%, p = 0.604) did not differ between the BID and QID lengthening group. (Table 2). Using IPTW, the result shows no significant effect of QID vs. BID lengthening on minor and major complications (Table 4).
DISCUSSION
This is the first study to clinically evaluate the effects of lengthening frequency on distraction osteogenesis (DO) for limb lengthening. We found that BID and QID lengthening did not significantly affect HI, callus quality, and minor and major complications.
Effects of Lengthening Frequency on Distraction Osteogenesis Outcomes
Mechanical factors have been shown to affect callus healing in DO significantly.1,3,7,8,15,16 The optimal distraction rate and mechanical techniques, such as distraction– compression, have improved osteogenesis in animal studies.17,18 However, the frequency of distraction appears to be of lesser interest and is used most frequently as a standard number. A classic in vivo study by Ilizarov3 showed that increasing the frequency of distraction positively affects osteogenesis activity; however, the frequency studied was one time/day, four times/day, and 60 times/day. Our study compares BID with QID lengthening, which might explain why the multivariate analysis shows a slight trend towards a better chance of achieving HI < 45 days/cm for the QID group, but the difference is not statistically significant. Therefore, the frequency difference might need to be greater to yield different clinical outcomes.
Mizuta et al. studied the frequency of distraction in a tibial open-edge osteotomies. They reported a higher
bone mineral density in the distraction area and a shorter external fixator time for patients who received eight-step distraction compared to four-step.15 A recent computational modeling study by Fu et al.19 suggested that a variable distraction rate could improve osteogenesis. Therefore, even though a BID lengthening frequency may cause less patient burden and confusion, it may not be the most suitable frequency of distraction.
The quality of callus formation has been associated with a decrease in HI and the subsidence rate of the callus.13,14 Although a higher frequency of distraction should lead to better callus quality due to improved osteogenesis activity, it did not show a significant result in a clinical setting. It is well known that many factors can affect the quality of HI and callus. The sample size may not be big enough, and the heterogeneity of patients is high, which may lead to a nonstatistically significant result.
The median healing index in our study is 42.8 days/ cm, which is comparable to other studies that did not use an intramedullary magnetic nail for lengthening.5,8,10,11,20-22 One of the significant factors influencing HI in our study is the bone lengthened being the femur. This is consistent with the findings of De Bastiani et al., Maffulli et al and Koczewski et al.10,11,22 The femur has more muscle enveloping the bone, resulting in a more robust blood supply and improved osteogenesis.
We found that congenital etiologies had a significantly lower probability of having HI<45days/cm. Maffuli et al. also observed a higher HI for congenital limb deficiency compared to acquired causes.10 Congenital limb deficiency is characterized not only by bone shorthening, but also by soft tissue contracture and joint instability. Therefore, complications frequently arise in these patients that may
TABLE 4. Average treatment effects (ATE) between QID and BID lengthening groups
Outcomes | QID1 | BID2 | Δ3 | p-value | |||
ATE4 | 95% CI | ||||||
Primary outcome (mean±SD) Healing index (days/cm) | 52.8±24.0 | 50.5±17.1 | 2.3 | -5.8 to 10.4 | 0.577 | ||
Secondary outcome (Risk, 95%CI) | |||||||
Good callus shape | 0.57 | 0.43 to 0.71 | 0.50 | 0.31 to 0.70 | 0.06 | -0.18 to 0.30 | 0.614 |
Good callus density | 0.34 | 0.21 to 0.48 | 0.41 | 0.22 to 0.60 | -0.07 | -0.30 to 0.17 | 0.577 |
Minor and major complications | 0.27 | 0.14 to 0.40 | 0.24 | 0.13 to 0.37 | 0.02 | -0.16 to 0.20 | 0.813 |
1QID, 4 times/ day; 2BID, 2 times/ day; 3Δ, differences; 4ATE, Average Treatment Effects
lead to increased HI. The inherent growth potential abnormality may also be a contributing factor.
Age is one of the most discussed factors regarding osteogenesis. We found that younger patients (less than ten years old) are more likely to achieve HI < 45 days/ cm. Many studies also show that older patients tend to have a higher HI with various cutpoints from ten to 18 years of age.8-10,22,23 The younger individual has a thicker periosteum and more robust blood supply with a higher re-modeling potential, leading to improved healing of the distraction site and decreased HI. Although our study did not achieve a significant statistical result, we agreed that the patient's age has a significant impact on the result of DO.
The increase in lengthening magnitude is also associated with a lower HI. Although the time in the distraction phase depends on the length needed, the time in the consolidation phase does not increase in the same proportion. This result is also evidenced in other studies.8,9,22 The device used for DO also affects HI. Aaron et al.24 found that the use of the Ilizarov apparatus resulted in a significantly lower healing index compared to the Wagner device. Our study reports the same result but without statistical significance.The Ilizarov method can provide a biomechanically stronger construction because it can incorporate fixation of wires and pins, resulting in greater engagement of the cortex.25 A more stable construct may contribute to a better mechanical environment and osteogenesis.
The distraction rate is typically one mm/day. However, many studies show that the actual distraction rate achieved is less than that and ranges from 0.5 – 0.8 mm/day.26-29 Balci et al. found that the lengthening speed of 0.56 mm/day is optimal for lengthening in congenital tibial dysplasia.30 We also reported a mean distraction rate of
0.73 mm/day and found that a distraction rate < 0.7 mm/ day results in almost statistically strong odds of achieving good HI. The importance of the distraction rate should be further investigated as the widely recommended rate of one mm/day might not be the most suitable for all patients.
Effects of Lengthening Frequency on Distraction Osteogenesis Complications
Our study reported a high rate of total complications. However, it is generally accepted that limb lengthening procedures are associated with many difficulties.5,7-10,24 Ankle equinus frequently accompanies tibial lengthening and is one of the most common complications.31 Our study reveals a similar result with the most common problems being ankle equinus and pin tract infection.
However, most of these problems were successfully treated during the DO period. Minor and major complications persist after the DO period and are considered significant for the patient’s outcome. We found that BID and QID lengthening results in similar minor and major complication rates. However, since not many patients faced significant complications, we may need more patients in a study to achieve a statistically significant difference.
Limitations
There are some limitations to our study. First, the DO in our research was done using either the Ilizarov apparatus or the monolateral fixator device. However, there are other methods for lengthenging, such as magnetic intramedullary nail lengthening and other integrated techniques, which also show promising results.27,32-34 Therefore, the results may not be directly applicable to other distraction techniques, and warrant further research. Second, many factors contribute to HI. Although we tried to control these factors using IPWT, we may still need a larger number of patients for a more accurate result. Furthermore, the heterogeneity of patients in the study might result in non-significant findings. A more extensive study focused on an interested subgroup, such as congenital limb deficiency, is still needed. Finally, although we cannot verify the effect of the lengthening frequency in this study, we still believe that it contributes significantly to the results of the DO. Therefore, further prospective studies are needed to prove the result.
CONCLUSION
BID and QID lengthening results in comparable HI and complications for patients who undergo distraction osteogenesis with either the Ilizarov or monolateral fixator. However, more research is required to evaluate the effect of lengthening frequency in a clinical setting.
ACKNOWLEDGMENTS
The authors thank Miss Suchitphon Chanchoo for her contribution to data analysis.
DECLARATIONS
On behalf of all authors, the corresponding author states that there is no conflict of interest
The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.
The authors have no relevant financial or non- financial interests to disclose.
REFERENCES
ILIZAROV GA. Clinical Application of the Tension–Stress Effect for Limb Lengthening. Clin Orthop Relat Res. 1990;250: 8-26.
Birch JG. A Brief History of Limb Lengthening. J Pediatr Orthop. 2017;37:S1-S8.
Ilizarov GA. The tension-stress effect on the genesis and growth of tissues: Part II. The influence of the rate and frequency of distraction. Clin Orthop Relat Res. 1989;239:263-85.
ILIZAROV GA. The Tension-Stress Effect on the Genesis and Growth of Tissues: Part I. The Influence of Stability of Fixation and Soft-Tissue Preservation. Clin Orthop Relat Res. 1989;238: 249-81.
Paley D. Problems, obstacles, and complications of limb lengthening by the Ilizarov technique. Clin Orthop Relat Res. 1990;250:81-104.
Watson JT. Distraction osteogenesis. J Am Acad Orthop Surg. 2006;14:S168-74.
Yasui N, Kojimoto H, Sasaki K, Kitada A, Shimizu H, Shimomura
Y. Factors affecting callus distraction in limb lengthening. Clin Orthop Relat Res. 1993;293:55-60.
FISCHGRUND J, PALEY D, SUTER C. Variables Affecting Time to Bone Healing During Limb Lengthening. Clin Orthop Relat Res. 1994;301:31-7.
Noonan KJ, Leyes M, Forriol F, Cañadell J. Distraction osteogenesis of the lower extremity with use of monolateral external fixation. A study of two hundred and sixty-one femora and tibiae. J Bone Joint Surg Am. 1998;80:793-806.
Maffulli N, Lombari C, Matarazzo L, Nele U, Pagnotta G, Fixsen JA. A review of 240 patients undergoing distraction osteogenesis for congenital post-traumatic or postinfective lower limb length discrepancy. J Am Coll Surg. 1996;182:394-402.
De Bastiani G, Aldegheri R, Renzi-Brivio L, Trivella G. Limb lengthening by callus distraction (callotasis). J Pediatr Orthop. 1987;7:129-34.
Lascombes P, Popkov D, Huber H, Haumont T, Journeau P. Classification of complications after progressive long bone lengthening: proposal for a new classification. Orthop Traumatol Surg Res. 2012;98:629-37.
Li R, Saleh M, Yang L, Coulton L. Radiographic classification of osteogenesis during bone distraction. J Orthop Res. 2006;24: 339-47.
Tirawanish P, Eamsobhana P. Prediction of Callus Subsidence in Distraction Osteogenesis Using Callus Formation Scoring System: Preliminary Study. Orthop Surg. 2018;10:121-7.
Mizuta H, Nakamura E, Kudo S, Maeda T, Takagi K. Greater frequency of distraction accelerates bone formation in open- wedge proximal tibial osteotomy with hemicallotasis. Acta Orthop Scand. 2004;75:588-93.
Schiller JR, Moore DC, Ehrlich MG. Increased lengthening rate decreases expression of fibroblast growth factor 2, platelet-derived growth factor, vascular endothelial growth factor, and CD31 in a rat model of distraction osteogenesis. J Pediatr Orthop. 2007; 27:961-8.
Liu Y, Cai F, Liu K, Liu J, Zhang X, Yusufu A. Cyclic Distraction- Compression Dynamization Technique Enhances the Bone Formation During Distraction Osteogenesis. Front Bioeng Biotechnol. 2021;9:810723.
Shen J, Ye X. Effect of "accordion" technique on bone consolidation during distraction osteogenesis. Zhongguo Xiu Fu Chong Jian
Wai Ke Za Zhi. 2018;32:558-67.
Fu R, Feng Y, Bertrand D, Du T, Liu Y, Willie BM, et al. Enhancing the Efficiency of Distraction Osteogenesis through Rate-Varying Distraction: A Computational Study. Int J Mol Sci. 2021;22(21):11734.
Horn J, Steen H, Huhnstock S, Hvid I, Gunderson RB. Limb lengthening and deformity correction of congenital and acquired deformities in children using the Taylor Spatial Frame. Acta Orthop. 2017;88:334-40.
Donnan LT, Saleh M, Rigby AS. Acute correction of lower limb deformity and simultaneous lengthening with a monolateral fixator. J Bone Joint Surg Br. 2003;85:254-60.
Koczewski P, Shadi M. Factors influencing bone regenerate healing in distraction osteogenesis. Ortop Traumatol Rehabil. 2013;15: 591-9.
Scheider P, Ganger R, Farr S. Age-related Outcomes and Complications of Osteodistraction in the Pediatric Upper Extremity: A Large Retrospective Single-center Study of 61 Cases. J Pediatr Orthop. 2022;42:e181-e7.
Aaron AD, Eilert RE. Results of the Wagner and Ilizarov methods of limb-lengthening. J Bone Joint Surg Am. 1996;78: 20-9.
Juan JA, Prat J, Vera P, Hoyos JV, Sánchez-Lacuesta J, Peris JL, et al. Biomechanical consequences of callus development in Hoffmann, Wagner, Orthofix and Ilizarov external fixators. J Biomech. 1992;25:995-1006.
Pietrzak S, Grzelecki D, Parol T, Czubak J. Comparison of Intramedullary Magnetic Nail, Monolateral External Distractor, and Spatial External Fixator in Femur Lengthening in Adolescents with Congenital Diseases. J Clin Med. 2021;10(24):5957.
Galal S, Shin J, Principe P, Mehta R, Khabyeh-Hasbani N, Hamilton A, et al. Humerus Lengthening: A Comparison of the Internal Lengthening Nail to External Fixation. Hss J. 2021;17: 207-12.
Szymczuk VL, Hammouda AI, Gesheff MG, Standard SC, Herzenberg JE. Lengthening With Monolateral External Fixation Versus Magnetically Motorized Intramedullary Nail in Congenital Femoral Deficiency. J Pediatr Orthop. 2019;39:458-65.
Jasiewicz B, Kacki W, Tesiorowski M, Potaczek T. Results of femoral lengthening over an intramedullary nail and external fixator. Chir Narzadow Ruchu Ortop Pol. 2008;73:177-83.
Balci H, Bayram S, Pehlivanoglu T, Anarat FB, Eralp L, Şen C, et al. Effect of lengthening speed on the quality of callus and complications in patients with congenital pseudarthrosis of tibia. Int Orthop. 2021;45:1517-22.
Van Nguyen L, Van Le D. Functional outcomes and complications of tibial lengthening using unilateral external fixation and then plating. A prospective case series. Ann Med Surg (Lond). 2022;74:103262.
Popkov A, Pietrzak S, Antonov A, Parol T, Lazović M, Podeszwa D, et al. Limb Lengthening for Congenital Deficiencies Using External Fixation Combined With Flexible Intramedullary Nailing: A Multicenter Study. J Pediatr Orthop. 2021;41:e439-e47.
Hafez M, Nicolaou N, Offiah A, Giles SN, Madan SS, Fernandes JA. Femoral Lengthening in Children-A Comparison Between Magnetic Intramedullary Lengthening Nails and External Fixators. J Pediatr Orthop. 2022;42:e290-e4.
Sheridan GA, Fragomen AT, Rozbruch SR. Integrated Limb Lengthening Is Superior to Classical Limb Lengthening: A Systematic Review and Meta-analysis of the Literature. J Am Acad Orthop Surg Glob Res Rev. 2020;4(6):e20.00054.